Posted inBusiness Insights
Piramal Pharma Braces for Massive ₹1,750 Crore Block Deal as Shares Edge Higher
Piramal Pharma shares rise as investors brace for a massive 1750 crore block deal with a major six percent stake sale on the horizon.
Posted inBusiness Insights
Eli Lilly’s Next-Generation Weight-Loss Drug Clears Critical Heart Safety Hurdle
Pharmaceutical giant Eli Lilly & Co. announced this week that its experimental, next-generation weight-loss therapy demonstrated no overall increase in cardiovascular risk in a major clinical evaluation, successfully clearing a…
Posted inBusiness Insights
Cipla Reaffirms Full-Year Profit Guidance as $1 Billion US Revenue Target Paves Way for FY27 Growth Ramp-Up
Indian pharmaceutical major Cipla Limited announced it is maintaining its full-year EBITDA margin guidance of 18.5% to 20%, anchored by a projected U.S. sales run rate of $1 billion by…
Posted inBusiness Insights
Kedaara Capital Leads Bid for Controlling Stake in Olive PharmaScience
Private equity firm Kedaara Capital has emerged as the frontrunner to acquire a significant stake in Olive PharmaScience, a strategic move that industry analysts value at approximately ₹4,500 crore. The…
Posted inEmerging Market
Medicare’s Landmark Coverage Shift: What Seniors Need to Know About Obesity Drug Access
Medicare now covers obesity drugs for heart health; learn how this landmark policy shift impacts your access to life-changing medication.
